Indol kinase inhibitors

Details Indol kinase inhibitors Indol kinase inhibitors

2006-07-11

2008-10-21

Anderson, Rebecca L (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C544S373000, C544S295000, C544S060000, C544S364000, C548S364700, C548S465000, C548S408000, C548S484000, C548S311100, C548S454000, C546S278400, C549S059000, C549S505000

Reexamination Certificate

active

07439371

ABSTRACT:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

REFERENCES:
patent: 5792783 (1998-08-01), Tang et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5883116 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 6541504 (2003-04-01), Andrews et al.
patent: 6559173 (2003-05-01), Andrews et al.
patent: 6699863 (2004-03-01), Andrews et al.
patent: 6747025 (2004-06-01), Andrews et al.
patent: 6765012 (2004-07-01), Andrews et al.
patent: 7005444 (2006-02-01), Andrews et al.
patent: 7015220 (2006-03-01), Andrews et al.
patent: 7060844 (2006-06-01), Andrews et al.
patent: WO99/15500 (1999-04-01), None
patent: WO03/027102 (2003-04-01), None
patent: WO2006/052936 (2006-05-01), None
Plowman et al, “Receptor Tyrosine Kinases as Targets for Drug Intervention”, 1994, DN&P 7(6): 334-339.
Bolen, “Nonreceptor tyrosine protein kinases”, 1993, Oncogen 8: pp. 2025-2031.

Affiliated with

Also associated with

Rating

Indol kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indol kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indol kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4009739